GL Pharm Tech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	69,717	84,606	75,097	70,834	46,578	76,699
Market Cap Growth	-29.78%	12.66%	6.02%	52.08%	-39.27%	12.04%
Enterprise Value	87,195	99,657	82,885	82,845	55,794	82,225
Last Close Price	899.00	1091.00	977.00	1136.00	750.00	1240.00
PE Ratio	-	6774.45	-	-	-	-
PS Ratio	1.89	2.40	2.88	2.72	2.78	6.17
PB Ratio	3.52	4.25	3.82	5.77	2.90	4.39
P/TBV Ratio	3.75	4.36	3.98	6.18	3.10	4.92
EV/Sales Ratio	2.37	2.83	3.18	3.18	3.34	6.62
EV/EBITDA Ratio	65.15	78.44	-	-	-	-
EV/EBIT Ratio	194.32	371.20	-	-	-	-
Debt / Equity Ratio	1.04	0.94	0.75	1.45	0.86	0.45
Debt / EBITDA Ratio	19.37	14.75	-	-	-	-
Net Debt / Equity Ratio	0.88	0.79	0.53	1.11	0.58	0.10
Net Debt / EBITDA Ratio	16.42	12.36	-180.25	-12.52	-8.35	-2.53
Net Debt / FCF Ratio	-2.98	-3.63	-2.06	-3.15	-1.20	-0.47
Asset Turnover	0.79	0.77	0.63	0.65	0.46	0.37
Inventory Turnover	2.23	2.15	2.08	2.86	2.67	2.83
Quick Ratio	0.47	0.48	0.74	0.81	0.79	2.02
Current Ratio	0.95	1.01	1.37	1.35	1.24	2.73
Return on Equity (ROE)	-0.67%	0.06%	-14.63%	-26.42%	-4.71%	-23.49%
Return on Assets (ROA)	0.23%	0.37%	-2.69%	-5.00%	-5.59%	-5.06%
Return on Invested Capital (ROIC)	0.48%	0.13%	-6.31%	-12.59%	-14.62%	-14.63%
Return on Capital Employed (ROCE)	0.70%	1.00%	-6.20%	-11.70%	-11.70%	-10.00%
Earnings Yield	-0.19%	0.01%	-3.11%	-5.29%	-1.70%	-4.86%
FCF Yield	-8.42%	-5.11%	-6.71%	-6.13%	-16.55%	-4.69%
Buyback Yield / Dilution	0.91%	-2.29%	-21.16%	-0.34%	-21.96%	-13.03%